News - Jazz Pharmaceuticals

Filter

Current filters:

Jazz Pharmaceuticals

Popular Filters

Jazz Pharma and Gentium debut Defitelio in Europe

31-03-2014

Ireland-headquartered Jazz Pharmaceuticals and its Italian subsidiary Gentium have initiated the European…

AustriaDefitelioEuropeGentiumGermanyJazz PharmaceuticalsMarkets & MarketingPharmaceuticalRare diseases

Jazz Pharma invests in first manufacturing facility in Ireland

10-02-2014

Specialty drugmaker Jazz Pharmaceuticals has commenced construction of a manufacturing and development…

DefitelioFinancialJazz PharmaceuticalsNorthern EuropePharmaceuticalProduction

Jazz Pharma in $397 million deal with Aerial for narcolepsy drug ADX-NO5

14-01-2014

Ireland-headquartered drugmaker Jazz Pharmaceuticals has inked an agreement with the USA’s Aerial BioPharma…

ADX-NO5Aerial BioPharmaGlobalJazz PharmaceuticalsLicensingNeurologicalPharmaceutical

Italy’s Gentium accepts $1 billion takeover offer from Jazz Pharma

20-12-2013

Ireland-headquartered drugmaker Jazz Pharmaceuticals has entered into a definitive agreement to acquire…

defibrotideDefitelioGentiumItalyJazz PharmaceuticalsMergers & AcquisitionsNephrology and HepatologyPharmaceuticalRare diseases

Jazz Pharma and Concert ink deal on deuterium-modified sodium oxybate

27-02-2013

US drugmakers Jazz Pharmaceuticals (Nasdaq: JAZZ) and Concert Pharmaceuticals have entered into an exclusive…

BiotechnologyConcert PharmaceuticalsJazz PharmaceuticalsLicensingNeurologicalPharmaceuticalResearchsodium oxybateZyrem

Landmark US court ruling reverses conviction on off-label drug promotion

05-12-2012

The US Court of Appeals for the Second Circuit (based in New York City) on December 3 issued a long-awaited…

Jazz PharmaceuticalsLegalMarkets & MarketingNorth AmericaPharmaceuticalRegulationXyrem

Jazz Pharma sells women's health business to Meda for $95 million

07-09-2012

US drugmaker Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced a definitive agreement to sell its women's…

Jazz PharmaceuticalsMedaMergers & AcquisitionsPharmaceuticalWomen's Health

Jazz Pharma to acquire EUSA Pharma for up to $700 million

29-04-2012

US drugmaker Jazz Pharmaceuticals (Nasdaq: JAZZ) said last week that it has signed a definitive accord…

EUSA PharmaJazz PharmaceuticalsMergers & AcquisitionsPharmaceutical

Executive appointments at Merck & Co, Actelion and Jazz Pharma

28-09-2011

US drug giant Merck & Co (NYSE: MRK) has appointed Cuong Viet Do as chief strategy officer, effective…

ActelionBiotechnologyJazz PharmaceuticalsManagementMerck & CoPharmaceutical

Azur Pharma agrees to all-stock merger with Jazz Pharma to create firm with $474 million revenues

20-09-2011

USA-based drugmaker Jazz Pharmaceuticals (Nasdaq: JAZZ) and privately-held Azur Pharma have agreed to…

Azur PharmaJazz PharmaceuticalsMergers & AcquisitionsPharmaceutical

Back to top